Sadeghniiat K, et al. Acta Med Iran 2013;51:784–88
Duman T et al. Ann Indian Acad Neurol 2015;18:298–302;
 Wang Sj, Kim BK, Wang H, et al. Efficacy and Safety of Erenumab 70 mg in Adult Patients with Chronic Migraine: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled DRAGON Study. Present at 2022 AAN Annual Meeting. S31.005.
Jessica Ailani, Rebecca C. Burch, Matthew S. Robbins, on behalf of the Board of Directors of the American Headache Society. Headache. 2021;61:1021–1039.
 Sacco et al. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. The Journal of Headache and Pain (2019) 20:6